Quantum-Si incorporated (NASDAQ:QSI – Get Free Report) saw some unusual options trading activity on Tuesday. Stock traders bought 16,070 call options on the company. This is an increase of approximately 137% compared to the typical daily volume of 6,783 call options.
Insider Activity
In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the firm’s stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the completion of the sale, the director now owns 1,250,000 shares in the company, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 30.04% of the company’s stock.
Institutional Trading of Quantum-Si
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. XTX Topco Ltd purchased a new position in Quantum-Si during the second quarter valued at approximately $25,000. SG Americas Securities LLC acquired a new stake in shares of Quantum-Si during the third quarter worth $53,000. Green Alpha Advisors LLC raised its stake in Quantum-Si by 35.4% in the 3rd quarter. Green Alpha Advisors LLC now owns 175,055 shares of the company’s stock worth $154,000 after acquiring an additional 45,796 shares during the last quarter. Barclays PLC lifted its holdings in shares of Quantum-Si by 210.5% during the third quarter. Barclays PLC now owns 196,826 shares of the company’s stock worth $173,000 after purchasing an additional 133,438 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in shares of Quantum-Si by 3.5% in the second quarter. Bank of New York Mellon Corp now owns 322,460 shares of the company’s stock worth $339,000 after acquiring an additional 10,811 shares during the period. Institutional investors own 39.90% of the company’s stock.
Quantum-Si Stock Performance
Wall Street Analyst Weigh In
Several research firms recently weighed in on QSI. HC Wainwright reaffirmed a “buy” rating and issued a $5.50 price objective on shares of Quantum-Si in a research note on Tuesday. Canaccord Genuity Group lowered their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th.
View Our Latest Research Report on Quantum-Si
About Quantum-Si
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
- Five stocks we like better than Quantum-Si
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Investing in Construction Stocks
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.